Risk Factors and Time to Occurrence of Genitourinary Toxicity After External Beam Radiotherapy for Prostate Cancer

被引：0
|
作者：
Kanemoto, Ayae [1 ]
Matsumoto, Yasuo [1 ]
Sugita, Tadashi [1 ]
Abe, Eisuke [3 ]
Yamana, Nobuko [3 ]
Saito, Toshihiro [2 ]
Kobayashi, Kazuhiro [2 ]
Yamazaki, Hiroyuki [2 ]
Bilim, Vladimir [2 ]
Tanikawa, Toshiki [2 ]
机构：
[1] Niigata Canc Ctr Hosp, Dept Radiat Oncol, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan
[2] Niigata Canc Ctr Hosp, Dept Urol, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan
[3] Niigata Univ, Med & Dent Hosp, Dept Radiat Oncol, Niigata, Japan
来源：
ANTICANCER RESEARCH | 2016年 / 36卷 / 05期
关键词：
Genitourinary toxicity; timing; risk factor; external-beam radiotherapy; prostate cancer; CONFORMAL RADIOTHERAPY; HORMONAL-THERAPY; DOSE-ESCALATION; TRIAL; OUTCOMES;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: To retrospectively investigate the risk factors and time to occurrence of genitourinary (GU) toxicity after radiotherapy for localized prostate cancer. Patients and Methods: The study included 320 patients. The radiotherapy planning target volume encompassed the prostate with a 1-cm margin in the transverse plane and a 1-cm margin (Group A) or a 1.5-cm margin (Group B) in the longitudinal plane. Incidence rates, risk factors and time to occurrence of GU toxicity were evaluated. Results: After a median follow-up of 38.2 months, the rate of late grade 2-3 GU toxicity was 5.9% and the median interval was 18.3 months. The wider longitudinal margin was the single significant independent factor. The 2-year cumulative incidence rates of late grade >= 2 GU toxicity were 2.8% and 7.5% in Group A and B patients. Conclusion: A wider radiotherapy margin increased the risk of GU toxicity and led to earlier occurrence.
引用
收藏
页码：2441 / 2444
页数：4
相关论文
共 50 条
  • [1] Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial
    Groen, Veerle H.
    van Schie, Marcel
    Zuithoff, Nicolaas P. A.
    Monninkhof, Evelyn M.
    Kunze-Busch, Martina
    de Boer, Johannes C. J.
    van Zijp, Jochem van der Voort
    Pos, Floris J.
    Smeenk, Robert Jan
    Haustermans, Karin
    Isebaert, Sofie
    Draulans, Cedric
    Depuydt, Tom
    Verkooijen, Helena M.
    van der Heide, Uulke A.
    Kerkmeijer, Linda G. W.
    RADIOTHERAPY AND ONCOLOGY, 2022, 167 : 127 - 132
  • [2] EXTERNAL BEAM RADIATION THERAPY AFTER TRANSURETHRAL RESECTION OF THE PROSTATE: A REPORT ON ACUTE AND LATE GENITOURINARY TOXICITY
    Devisetty, Kiran
    Zorn, Kevin C.
    Katz, Mark H.
    Jani, Ashesh B.
    Liauw, Stanley L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1060 - 1065
  • [3] Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
    D'Avino, Vittoria
    Palma, Giuseppe
    Liuzzi, Raffaele
    Conson, Manuel
    Doria, Francesca
    Salvatore, Marco
    Pacelli, Roberto
    Cella, Laura
    RADIATION ONCOLOGY, 2015, 10
  • [4] Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer
    Pinkawa, Michael
    Gagel, Bernd
    Piroth, Marc D.
    Fischedick, Karin
    Asadpour, Branka
    Kehl, Mareike
    Klotz, Jens
    Eble, Michael J.
    EUROPEAN UROLOGY, 2009, 55 (01) : 227 - 236
  • [5] Anorectal toxicity of external beam radiotherapy in the treatment of prostate cancer
    Bajwa, Adeel
    Raeburn, Amanda
    Taylor, Stuart
    Cohen, Richard
    Payne, Heather
    Emmanuel, Anton
    JOURNAL OF CLINICAL UROLOGY, 2014, 7 (03) : 185 - 189
  • [6] Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy
    Sutani, Shinya
    Ohashi, Toshio
    Sakayori, Masanori
    Kaneda, Tomoya
    Yamashita, Shoji
    Momma, Tetsuo
    Hanada, Takashi
    Shiraishi, Yutaka
    Fukada, Junichi
    Oya, Mototsugu
    Shigematsu, Naoyuki
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (02) : 270 - 276
  • [7] Stereotactic body radiotherapy as a boost after external beam radiotherapy for high-risk prostate cancer patients
    Turna, Menekse
    Akboru, Halil
    Ermis, Ekin
    Oskeroglu, Sedenay
    Dincer, Selvi
    Altin, Suleyman
    INDIAN JOURNAL OF CANCER, 2021, 58 (04) : 518 - 524
  • [8] TIME OF DECLINE IN SEXUAL FUNCTION AFTER EXTERNAL BEAM RADIOTHERAPY FOR PROSTATE CANCER
    Siglin, Joshua
    Kubicek, Gregory J.
    Leiby, Benjamin
    Valicenti, Richard K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 31 - 35
  • [9] Combined External Radiotherapy and Hormone Therapy in Patients with Locally Advanced Prostate Cancer: Predictive Factors of Genitourinary Toxicity
    Ferrandis, C.
    March, J. A.
    Martinez, J. M.
    Hernandez, J.
    Diez, N.
    Morillo, V.
    Garcia, F.
    Chuan, P.
    ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (03): : 146 - 151
  • [10] Acute and late genitourinary toxicity of conformal radiotherapy for prostate cancer
    Yoshimura R.-I.
    Iwata M.
    Shibuya H.
    Sakai Y.
    Kihara K.
    Radiation Medicine, 2006, 24 (8): : 553 - 559
12345